IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the long island breast cancer study project

Carcinogenesis

Volumn 27, Issue 4, 2006, Pages 758-765

  Cleveland, Rebecca J ^a   Gammon, Marilie D ^a   Edmiston, Sharon N ^b   Teitelbaum, Susan L ^f   Britton, Julie A ^f   Terry, Mary Beth ^c   Eng, Sybil M ^g   Neugut, Alfred I ^c,e   Santella, Regina M ^d   Conway, Kathleen ^a,b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Global Epidemiology Safety and Risk Management ^*  (United States)

^e NONE   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CONTRACEPTIVE AGENT; CYTOSINE; SOMATOMEDIN C;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CELL DIFFERENTIATION; CELL GROWTH; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LIFESTYLE; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; MIDDLE AGED; NEW YORK; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33645353875     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi294     Document Type: Article

References (56)

1. Daughaday,W.H. and Rotwein,P. (1989) Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev., 10, 68-91.
2. LeRoith,D., Raizada,M.K (ed.). (1993) Proceedings of the 4th International Symposium on Insulin, IGFs, and their Receptors. Woods Hole, Massachusetts, April 20-23, 1993. Adv. Exp. Med. Biol., 343, 1-417.
3. LeRoith,D., Werner,H., Beitner-Johnson,D. and Roberts,C.T.,Jr. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev., 16, 143-163.
4. Jones,J.I. and Clemmons,D.R. (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev., 16, 3-34.
5. Shimasaki,S. and Ling,N. (1991) Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res., 3, 243-266.
6. Chan,J.M., Stampfer,M.J., Giovannucci,E., Gann,P.H., Ma,J., Wilkinson,P., Hennekens,C.H. and Pollak,M. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science, 279, 563-566.
7. Hankinson,S.E., Willett,W.C., Colditz,G.A., Hunter,D.J., Michaud,D.S., Deroo,B., Rosner,B., Speizer,F.E. and Pollak,M. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351, 1393-1396.
8. Ma,J., Pollak,M.N., Giovannucci,E., Chan,J.M., Tao,Y., Hennekens,C.H. and Stampfer,M.J. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl Cancer Inst., 91, 620-625.
9. Jernstrom,H., Deal,C., Wilkin,F., Chu,W., Tao,Y., Majeed,N., Hudson,T., Narod,S.A. and Pollak,M. (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol. Biomarkers Prev., 10, 377-384.
10. Allen,N.E., Appleby,P.N., Kaaks,R., Rinaldi,S., Davey,G.K. and Key,T.J. (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control, 14, 65-74.
11. Lukanova,A., Soderberg,S., Stattin,P., Palmqvist,R., Lundin,E., Biessy,C., Rinaldi,S., Riboli,E., Hallmans,G. and Kaaks,R. (2002) Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/ IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control, 13, 509-516.
12. Roelen,C.A., de Vries,W.R., Koppeschaar,H.P., Vervoorn,C., Thijssen,J.H. and Blankenstein,M.A. (1997) Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training. Int. J. Sports Med., 18, 238-241.
13. Thissen,J.P., Ketelslegers,J.M. and Underwood,L.E. (1994) Nutritional regulation of the insulin-like growth factors. Endocr. Rev., 15, 80-101.
14. Yee,D. and Lee,A.V. (2000) Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J. Mammary Gland Biol. Neoplasia., 5, 107-115.
15. Toniolo,P., Bruning,P.F., Akhmedkhanov,A., Bonfrer,J.M., Koenig,K.L., Lukanova,A., Shore,R.E. and Zeleniuch-Jacquotte,A. (2000) Serum insulin-like growth factor-I and breast cancer. Int. J. Cancer, 88, 828-832.
16. Muti,P., Quattrin,T., Grant,B.J., Krogh,V., Micheli,A., Schunemann,H.J., Ram,M., Freudenheim,J.L., Sieri,S., Trevisan,M. and Berrino,F. (2002) Fasting glucose is a risk factor for breast cancer: A prospective study. Cancer Epidemiol. Biomarkers Prev., 11, 1361-1368.
17. Harrela,M., Koistinen,H., Kaprio,J. et al. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J. Clin. Invest., 98, 2612-2615.
18. Hong,Y., Pedersen,N.L., Brismar,K., Hall,K. and de Faire,U. (1996) Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J. Clin. Endocrinol. Metab., 81, 1791-1797.
19. Weber,J.L. and May,P.E. (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet., 44, 388-396.
20. Tae,H.J., Luo,X. and Kim,K.H. (1994) Roles of CCAAT/enhancer-binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene. J. Biol. Chem., 269, 10475-10484.
21. Gebhardt,F., Zanker,K.S. and Brandt,B. (1999) Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J. Biol. Chem., 274, 13176-13180.
22. Missmer,S.A., Haiman,C.A., Hunter,D.J., Willett,W.C., Colditz,G.A., Speizer,F.E., Pollak,M.N. and Hankinson,S.E. (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int. J. Cancer, 100, 332-336.
23. DeLellis,K., Ingles,S., Kolonel,L., McKean-Cowdin,R., Henderson,B., Stanczyk,F. and Probst-Hensch,N.M. (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J. Cancer, 88, 277-282.
24. Yu,H., Li,B.D., Smith,M., Shi,R., Berkel,H.J. and Kato,I. (2001) Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res. Treat, 70, 117-122.
25. Figer,A., Karasik,Y.P., Baruch,R.G., Chetrit,A., Papa,M.Z., Sade,R.B., Riezel,S. and Friedman,E. (2002) Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr. Med. Assoc. J., 4, 759-762.
26. Gammon,M.D., Neugut,A.I., Santella,R.M. et al. (2002) The Long Island Breast Cancer Study Project: Description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res. Treat, 74, 235-254.
27. Waksberg,J. (1978) Sampling methods for random digit dialing. J. Amer Statistic Assoc., 73, 40-46.
28. Hosmer,D. and Lemeshow,S. (1989) Applied logistic regression. John Wiley & Sons, New York.
29. Jernstrom,H. and Olsson,H. (1994) Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives. Gynecol. Obstet. Invest., 38, 261-265.
30. Bellantoni,M.F., Vittone,J., Campfield,A.T., Bass,K.M., Harman,S.M. and Blackman,M.R. (1996) Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: A clinical research center study. J. Clin. Endocrinol. Metab., 81, 2848-2853.
31. Chang,S., Wu,X., Yu,H. and Spitz,M.R. (2002) Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: Associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol. Biomarkers Prev., 11, 758-766.
32. Kaaks,R. and Lukanova,A. (2001) Energy balance and cancer: The role of insulin and insulin-like growth factor-I. Proc Nutr Soc., 60, 91-106.
33. Rothman,K.J., G.S. (1998) Modern Epidemiology. Lippincott-Raven Publishers, Philadelphia, PA.
34. Frayling,T.M., Hattersley,A.T., McCarthy,A., Holly,J., Mitchell,S.M., Gloyn,A.L., Owen,K., Davies,D., Smith,G.D. and Ben-Shlomo,Y. (2002) A putative functional polymorphism in the IGF-I gene: Association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes, 51, 2313-2316.
35. Bruning,P.F., Van Doorn,J., Bonfrer,J.M., Van Noord,P.A., Korse,C.M., Linders,T.C. and Hart,A.A. (1995) Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int. J. Cancer, 62, 266-270.
36. Kaaks,R., Lundin,E., Rinaldi,S. et al. (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control, 13, 307-316.
37. Jernstrom,H. and Barrett-Connor,E. (1999) Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: The Rancho Bernardo Study. J. Womens Health Gend Based Med, 8, 1265-1272.
38. Petridou,E., Papadiamantis,Y., Markopoulos,C., Spanos,E., Dessypris,N. and Trichopoulos,D. (2000) Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control, 11, 383-388.
39. Macaulay,V.M. (1992) Insulin-like growth factors and cancer. Br J. Cancer, 65, 311-320.
40. Karey,K.P. and Sirbasku,D.A. (1988) Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Cancer Res., 48, 4083-4092.
41. Pollak,M., Costantino,J., Polychronakos,C., Blauer,S.A., Guyda,H., Redmond,C., Fisher,B. and Margolese,R. (1990) Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. J. Natl Cancer Inst., 82, 1693-1697.
42. Ng,S.T., Zhou,J., Adesanya,O.O., Wang,J., LeRoith,D. and Bondy,C.A. (1997) Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat. Med., 3, 1141-1144.
43. Wen,W., Gao,Y.T., Shu,X.O., Yu,H., Cai,Q., Smith,J.R. and Zheng,W. (2005) Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int. J. Cancer, 113, 307-311.
44. Yu,H., Jin,F., Shu,X.O., Li,B.D., Dai,Q., Cheng,J.R., Berkel,H.J. and Zheng,W. (2002) Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol. Cancer Epidemiol Biomarkers Prev., 11, 705-712.
45. Jernstrom,H., Chu,W., Vesprini,D., Tao,Y., Majeed,N., Deal,C., Pollak,M. and Narod,S.A. (2001) Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk. Mol. Genet. Metab., 72, 144-54.
46. Rosen,C.J., Kurland,E.S., Vereault,D., Adler,R.A., Rackoff,P.J., Craig,W.Y., Witte,S., Rogers,J. and Bilezikian,J.P. (1998) Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density. J. Clin. Endocrinol. Metab., 83, 2286-2290.
47. Vaessen,N., Heutink,P., Janssen,J.A., Witteman,J.C., Testers,L., Hofman,A., Lamberts,S.W., Oostra,B.A., Pols,H.A. and van Duijn,C.M. (2001) A polymorphism in the gene for IGF-I: Functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes, 50, 637-642.
48. Rietveld,I., Janssen,J.A., Hofman,A., Pols,H.A., van Duijn,C.M. and Lamberts,S.W. (2003) A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur. J. Endocrinol., 148, 171-175.
49. Collaborative Group on Hormonal Factors in Breast Cancer. (1996) Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet, 347, 1713-1727.
50. Holmes,M.D., Pollak,M.N. and Hankinson,S.E. (2002) Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol. Biomarkers Prev., 11, 862-867.
51. Goodman-Gruen,D. and Barrett-Connor,E. (1996) Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo Study. J. Clin. Endocrinol. Metab., 81, 4268-4271.
52. van den Brandt,P.A., Spiegelman,D., Yaun,S.S. et al. (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am. J. Epidemiol., 152, 514-527.
53. Colletti,R.B., Copeland,K.C., Devlin,J.T., Roberts,J.D. and McAuliffe,T.L. (1991) Effect of obesity on plasma insulin-like growth factor-I in cancer patients. Int. J. Obes., 15, 523-527.
54. Nam,S.Y., Lee,E.J., Kim,K.R., Cha,B.S., Song,Y.D., Lim,S.K., Lee,H.C. and Huh,K.B. (1997) Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int. J. Obes. Relat. Metab. Disord., 21, 355-359.
55. Chapman,I.M., Hartman,M.L., Pieper,K.S., Skiles,E.H., Pezzoli,S.S., Hintz,R.L. and Thorner,M.O. (1998) Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J. Clin. Endocrinol. Metab., 83, 2836-2842.
56. Lukanova,A., Lundin,E., Zeleniuch-Jacquotte,A. et al. (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: A cross-sectional study in healthy women. Eur. J. Endocrinol., 150, 161-171.